San Donato Hospital
Lymphoma treatment cost in Italy typically includes essential procedures such as a PET/CT scan running from $1,200 to $1,800 and chemotherapy which ranges from $3,500 to $7,500 per course. The total expense depends on the lymphoma subtype, disease stage, and the need for advanced interventions like CAR T-cell therapy or stem cell transplants. Patients often find 30-50% savings compared to prices in the United States. Milan and Rome are the primary destinations for high-quality hematological care.
Typical Lymphoma Treatment Costs in Italy
Bookimed Expert Insight: Advanced or refractory lymphoma cases benefit most from academic research hospitals. San Raffaele in Milan is a top choice, performing over 8,400 operations annually with IRCCS accreditation. For patients requiring specialized transplants, Professor Fabio Ciceri at San Raffaele provides world-class expertise in cell and gene therapy. This center is ideal for complex cases where multidisciplinary research and clinical trials offer the best value.
| Italy | Turkey | Austria | |
| Radiation therapy for colorectal cancer | from $7,000 | from $7,000 | from $12,000 |
| Chemotherapy for breast cancer | from $4,500 | from $1,200 | from $15,000 |
| Chemotherapy | from $3,500 | from $2,430 | from $2,500 |
| CAR T-cell therapy | from $350,000 | from $150,000 | from $350,000 |
| Bone marrow transplantation | from $95,000 | from $36,000 | from $140,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Lymphoma treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Lymphoma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Lymphoma treatment journey.
Head of Bone Marrow Transplant Department at San Raffaele – one of Italy's largest centers with 90+ transplants yearly. Specializes in lymphoma treatment.
Director of the Lymphoma Unit at San Raffaele Scientific Institute – Professor Ferreri founded the Italian Lymphoma Foundation dedicated to clinical studies in lymphoma management.
Head of Hematology and Bone Marrow Transplantation at San Raffaele – leading clinical trials in cell and gene therapy for blood cancers.
Written by Anna Leonova
Written by Halina Shubala
Lymphoma treatment in Italy is world-class. Leading centers like San Raffaele specialize in advanced therapies. Facilities often hold Joint Commission International and IRCCS accreditations. Italian oncology centers report up to 85% survival rates for early-stage cases. Experts perform over 52,000 operations annually in top Milanese hospitals.
Bookimed Expert Insight: Italian research hospitals offer unique value by combining academic research with clinical care. Dr. Fabio Ciceri and Dr. Jacopo Peccatori focus on complex cell and gene therapies. Their unit performs 90 allogeneic transplants annually. This high volume often leads to better outcomes in rare lymphoma subtypes. Patients should prioritize Milan-based clinics for the highest concentration of specialized hematological expertise.
Patient Consensus: Patients note the medical staff are very professional and empathetic. Many travelers emphasize that the personalized care and technology match top US centers.
Advanced CAR T-cell therapy is available in Italy for lymphoma patients. Specialized centers like San Raffaele in Milan and Gemelli in Rome provide these innovative treatments. Eligibility is managed through the AIFA Registry. Patients often access these therapies for conditions like DLBCL after other treatments fail.
Bookimed Expert Insight: San Raffaele Hospital is a premier choice for complex hematology due to its high volume and research depth. Professor Fabio Ciceri and Professor Andres Jose Maria Ferreri have published over 480 scientific papers combined. This academic focus ensures patients access the latest lymphoma protocols and clinical trials not available at standard hospitals. Their success in performing the worlds first stem cell therapy for ADA-SCID highlights their expertise in genetic and cellular medicine.
Patient Consensus: Patients note that while the process can take 2 to 3 months for approval, the results are life-saving after a relapse. Those from southern regions mentioned they often relocate to northern cities like Milan or Bologna to access these specialized treatments more quickly.
Italy reports high lymphoma success rates. Hodgkin lymphoma centers achieve 92.5% survival for first-line therapies. Specialized units report 100% cure rates for low-risk Burkitt lymphoma. Italian oncologists utilize CAR T-cell therapy and allogeneic bone marrow transplants to improve outcomes for advanced cases.
Bookimed Expert Insight: Data shows Milan is the primary hub for complex lymphoma care. San Raffaele Hospital performs 90 allogeneic transplants annually. Dr. Andres Jose Maria Ferreri founded the Italian Lymphoma Foundation to standardize high success rates. Choosing research-heavy IRCCS institutions ensures access to the latest cell and gene therapy protocols.
Patient Consensus: Patients note that Italian clinics offer survival outcomes matching Nordic standards. Many find that private care provides significantly faster access to specialists than international public systems.
Top specialized lymphoma centers in Italy include San Raffaele Hospital and Fondazione IRCCS Istituto Nazionale dei Tumori in Milan. These facilities hold IRCCS accreditation for combining research with clinical care. They offer advanced therapies such as CAR T-cell therapy and bone marrow transplants for complex hematological cases.
Bookimed Expert Insight: San Raffaele Hospital offers a unique advantage for patients with rare or resistant lymphoma. Professor Andres Ferreri, the founder of the Italian Lymphoma Foundation, leads the Lymphoma Unit there. Our data shows his department performs 90 related and unrelated allogeneic transplants every year. This high volume directly correlates with their expertise in managing complex stem cell therapies and rare immune disorders.
Patient Consensus: Patients note that traveling to northern university hospitals often speeds up treatment by months. Many specifically recommend finding specialists like those at San Raffaele who are empathetic and highly professional.
International patients can access specialized lymphoma treatment in Italy by choosing private healthcare pathways. Non-EU citizens typically require a Schengen Medical Visa and a hospital invitation. Facilities like San Raffaele in Milan provide advanced hematology care including bone marrow transplants and CAR T-cell therapy.
Bookimed Expert Insight: While the Italian public system is resident-focused, seeking care at IRCCS-accredited research hospitals like San Raffaele ensures access to clinical trials. Dr. Jacopo Peccatori at this facility performs 90 allogeneic transplants yearly. This volume-to-outcome ratio is a primary quality indicator for international patients seeking hematological stability.
Patient Consensus: Patients note it's important to book private clinics to avoid the months-long waits found in the public system. The medical staff is described as empathic, professional, and very nice in modern, well-equipped Milanese facilities.
Italy offers lymphoma treatments like CAR T-cell therapy at accredited specialist research hospitals. These centres provide therapies like Yescarta and Kymriah for specific relapsed B-cell malignancies. Treatment is concentrated in major units with established cellular therapy programmes.
Bookimed Expert Insight: San Raffaele performs stem cell therapies and leads cell therapy clinical trials. This clinic carries IRCCS accreditation from the Italian Ministry of Health. This status signifies it as a research-active institution. Patients benefit from doctors like Dr Fabio Ciceri, who has published 180 papers on haematological cancers.
Patient Consensus: Patients find the Italian medical staff empathetic and professional during complex treatments. Experience shows it is vital to choose established cellular therapy programmes in Italy. This helps manage manufacturing timelines and monitoring.
Italy specialises in lymphoma treatment through IRCCS-accredited research hospitals, primarily in Milan and Rome. These centres provide CAR T-cell therapy, allogeneic bone marrow transplants, and clinical trials. Leading facilities like San Raffaele use multidisciplinary teams for complex Hodgkin and non-Hodgkin lymphoma cases.
Bookimed Expert Insight: San Raffaele stands out because its specialists are active clinical trial investigators. Dr Andres Ferreri founded the Italian Lymphoma Foundation and has published over 300 papers. This academic focus means patients often access newer protocols before they become standard care. Dr Jacopo Peccatori also leads a unit performing 90 donor allogeneic transplants annually. This shows high-volume expertise.
Patient Consensus: Patients in Italy value the empathy of the medical staff at major Milanese hospitals. They suggest prioritising high-volume IRCCS institutes over private clinics. This helps to ensure access to essential PET/CT staging and specialist haematology boards.
Italian cancer centres offer international lymphoma patients access to clinical trials through specialised research institutes (IRCCS). Facilities like San Raffaele in Milan conduct trials for cell and gene therapies. These protocols often target relapsed or refractory cases using CAR T-cell therapy and stem cell treatments.
Bookimed Expert Insight: Data shows that Milan is the primary hub for lymphoma research in Italy. Dr Andres Jose Maria Ferreri, who founded the Italian Lymphoma Foundation, works at San Raffaele. Choosing a centre where the department head leads national research foundations often provides faster updates on trial openings.
Patient Consensus: Patients describe the medical staff in Milan as professional and empathetic. Providing translated pathology reports and PET scans early helps specialists perform remote pre-screens before travel to Italy.
Private lymphoma treatment in Italy offers much faster access to specialists and diagnostics than the public system. Patients bypass long administrative queues. This allows for immediate consultations and rapid treatment. Research hospitals like San Raffaele in Milan provide oncohaematology care without public waitlists.
Bookimed Expert Insight: Private care accelerates initial diagnostics, but clinical depth matters for lymphoma. San Raffaele performs 52,000 operations annually. It houses specialised units for rare genetic diseases. Choosing a private department within an IRCCS-accredited research hospital ensures speed and academic-level medicine.
Patient Consensus: Patients note that going private in Italy speeds up first steps like imaging and staging. They find the medical staff professional and empathetic throughout the diagnostic process.
Italian medical centres provide English language support for lymphoma treatment. This is common in research hospitals in Milan and Rome. Specialists at major centres often hold international credentials and speak English fluently. Leading facilities have dedicated international departments to help with translation and logistics.
Bookimed Expert Insight: Many doctors are fluent, but administrative staff proficiency varies between facilities. Patients benefit most from centres like San Raffaele in Milan. Dr Jacopo Peccatori leads one of Italy's largest transplant units there. His team performs 90 allogeneic transplants yearly. This experience helps them manage complex international cases.
Patient Consensus: Patients find medical staff in Italy very empathic and professional. They suggest bringing previous medical reports in English to help with consultations. Having a companion can help with tasks like pharmacy visits and discharge paperwork.